Radiation treatment for certain kidney tumors
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a focused, high-dose radiation treatment (SABR) for kidney tumors that are too risky to remove with surgery or where surgery was declined. It may help shrink the tumor while limiting damage to surrounding tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a kidney tumor (either a primary kidney cancer or a spread kidney tumor) that is treatable with SABR if it measures 6 cm or less
- The tumor has been identified by scan or biopsy (histology or imaging diagnosis)
- Surgery is not possible or is considered high-risk, or you chose not to have surgery
- Your general health allows you to do daily activities with an ECOG score of 0 to 3
- You do NOT have 5 or more active metastases (spread to multiple sites)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a precise radiation technique called SABR to treat cancer that has spread to a few spots. It aims to see if this approach can help control the cancer better than usual treatment, especially for lung, prostate, colorectal, or other solid tumors with limited spread.
This study tests whether a very focused type of radiation (SABR) can control a small number of prostate cancer spots that are starting to grow while you’re already on abiraterone. It may help by treating only the areas that are progressing, while other areas remain controlled.
This study tests whether a precise, high-dose radiation treatment (SABR) can safely control kidney cancer that has spread to a few spots in the body. It may be an option if your cancer is progressing during treatment and your spots can be safely targeted with radiation.
This trial tests a precise type of radiation therapy for small, early-stage kidney tumors that cannot be surgically removed or are at high risk for surgery. It aims to offer an alternative treatment with fewer side effects.
This trial tests combining a precise type of radiation (SABR) with standard targeted therapy and immunotherapy drugs for kidney cancer that has come back or spread. The goal is to see if adding radiation improves outcomes.
This trial uses a precise form of radiation therapy called stereotactic body radiotherapy (SBRT) that tracks the tumor during treatment to destroy kidney tumors without surgery. It may be an option if you have a kidney tumor (primary or spread from another cancer) up to 10 cm in size and you haven't had radiation to that area before.
Hear when a new Renal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.